Abstract
Inhibitory postsynaptic currents were measured in CA1 pyramidal cells from chronically epileptic rats (pilocarpine model). Tiagabine, a selective inhibitor of the GABA-uptake transporter 1 prolonged currents equally to cells from control animals. Thus, GABA-uptake has an unaltered impact on inhibitory synaptic efficacy in rats with chronic temporal lobe epilepsy, underlining the rational for the use of GABA-uptake blockers in this condition.
MeSH terms
-
Animals
-
Chronic Disease
-
Disease Models, Animal
-
Epilepsy / chemically induced
-
Epilepsy / metabolism*
-
GABA Agonists / pharmacology
-
Hippocampus / cytology*
-
In Vitro Techniques
-
Membrane Potentials / drug effects
-
Membrane Potentials / physiology
-
Membrane Potentials / radiation effects
-
Muscarinic Agonists / pharmacology
-
Neural Inhibition / drug effects
-
Neural Inhibition / physiology*
-
Neurons / drug effects
-
Neurons / physiology*
-
Nipecotic Acids / pharmacology
-
Patch-Clamp Techniques / methods
-
Pilocarpine / pharmacology
-
Rats
-
Synapses / drug effects
-
Synapses / metabolism*
-
Tiagabine
-
gamma-Aminobutyric Acid / metabolism*
Substances
-
GABA Agonists
-
Muscarinic Agonists
-
Nipecotic Acids
-
Pilocarpine
-
gamma-Aminobutyric Acid
-
Tiagabine